Trial Profile
Long-Term Safety and Efficacy of FYX-051 in Patients with Hyperuricemia (with or without Gout)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jul 2018
Price :
$35
*
At a glance
- Drugs Topiroxostat (Primary)
- Indications Hyperuricaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Fuji Yakuhin
- 27 May 2016 New trial record